Axon Enterprise, Inc. (NASDAQ:AXON) Shares Purchased by Natixis Advisors LLC

Natixis Advisors LLC boosted its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 5.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 30,392 shares of the biotechnology company's stock after acquiring an additional 1,552 shares during the period. Natixis Advisors LLC's holdings in Axon Enterprise were worth $12,145,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Mizuho Securities USA LLC grew its position in Axon Enterprise by 1,077.9% during the third quarter. Mizuho Securities USA LLC now owns 64,418 shares of the biotechnology company's stock worth $25,741,000 after buying an additional 58,949 shares in the last quarter. Empirical Finance LLC grew its holdings in shares of Axon Enterprise by 9.8% during the third quarter. Empirical Finance LLC now owns 1,038 shares of the biotechnology company's stock worth $415,000 after purchasing an additional 93 shares in the last quarter. Signature Estate & Investment Advisors LLC bought a new position in shares of Axon Enterprise in the third quarter worth approximately $210,000. CIBC Asset Management Inc raised its stake in Axon Enterprise by 9.2% in the third quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company's stock valued at $4,227,000 after purchasing an additional 895 shares in the last quarter. Finally, OneDigital Investment Advisors LLC lifted its position in Axon Enterprise by 35.8% during the third quarter. OneDigital Investment Advisors LLC now owns 2,053 shares of the biotechnology company's stock valued at $820,000 after purchasing an additional 541 shares during the last quarter. Institutional investors own 79.08% of the company's stock.

Wall Street Analysts Forecast Growth

AXON has been the topic of a number of research reports. The Goldman Sachs Group raised their price target on Axon Enterprise from $385.00 to $441.00 and gave the company a "buy" rating in a research report on Wednesday, October 23rd. Robert W. Baird boosted their target price on Axon Enterprise from $440.00 to $460.00 and gave the stock an "outperform" rating in a research report on Monday, November 4th. Craig Hallum increased their price target on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a "buy" rating in a research report on Wednesday, August 7th. JMP Securities boosted their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a "market outperform" rating in a report on Thursday, October 31st. Finally, Barclays increased their target price on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an "overweight" rating in a report on Wednesday, August 7th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $427.83.

Insider Buying and Selling

In other news, Director Julie A. Cullivan sold 900 shares of the stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $353.53, for a total transaction of $318,177.00. Following the sale, the director now owns 3,653 shares of the company's stock, valued at approximately $1,291,445.09. This represents a 19.77 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Brittany Bagley sold 4,338 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the sale, the chief financial officer now owns 98,825 shares in the company, valued at approximately $37,449,733.75. This trade represents a 4.20 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 410,556 shares of company stock valued at $161,192,754. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Trading Down 0.1 %

NASDAQ AXON opened at $609.82 on Thursday. The company's 50-day simple moving average is $453.48 and its two-hundred day simple moving average is $363.68. Axon Enterprise, Inc. has a one year low of $224.28 and a one year high of $624.84. The company has a market capitalization of $46.50 billion, a price-to-earnings ratio of 157.58, a price-to-earnings-growth ratio of 18.26 and a beta of 0.94. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.